These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32341498)

  • 1. Molecular and clinicopathologic characterization of intravenous leiomyomatosis.
    Ordulu Z; Chai H; Peng G; McDonald AG; De Nictolis M; Garcia-Fernandez E; Hardisson D; Prat J; Li P; Hui P; Oliva E; Buza N
    Mod Pathol; 2020 Sep; 33(9):1844-1860. PubMed ID: 32341498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
    Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
    Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing.
    Zhang X; Wu L; Xu R; Zhu C; Ma G; Zhang C; Liu X; Zhao H; Miao Q
    Sci Rep; 2019 Feb; 9(1):1442. PubMed ID: 30723247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
    Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
    Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
    Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
    Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
    Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous leiomyomatosis of the uterus: A clinicopathologic analysis of 13 cases with an emphasis on histogenesis.
    Tang L; Lu B
    Pathol Res Pract; 2018 Jun; 214(6):871-875. PubMed ID: 29699902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.
    Quade BJ; Dal Cin P; Neskey DM; Weremowicz S; Morton CC
    Mod Pathol; 2002 Mar; 15(3):351-6. PubMed ID: 11904348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous leiomyomatosis of the uterus.
    Arora R; Abou-Bakr AA; Ahmad MS
    Gulf J Oncolog; 2010 Jan; (7):57-9. PubMed ID: 20164011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center.
    Carr RJ; Hui P; Buza N
    Int J Gynecol Pathol; 2015 Mar; 34(2):169-76. PubMed ID: 25675187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and clinical outcomes of intravenous leiomyomatosis of the uterus: A case series.
    Yu X; Fu J; Cao T; Huang L; Qie M; Ouyang Y
    Medicine (Baltimore); 2021 Jan; 100(1):e24228. PubMed ID: 33429819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.
    Barnaś E; Skręt-Magierło JE; Paszek S; Kaznowska E; Potocka N; Skręt A; Sakowicz A; Zawlik I
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
    Lee HJ; Choi J; Kim KR
    Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous leiomyomatosis of the uterus].
    Banaczek Z; Woźniak M; Grzeszczyk J
    Ginekol Pol; 2003 Feb; 74(2):159-61. PubMed ID: 12715427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous leiomyomatosis of the uterus. A report of three cases.
    Andrade LA; Torresan RZ; Sales JF; Vicentini R; De Souza GA
    Pathol Oncol Res; 1998; 4(1):44-7. PubMed ID: 9555121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.
    Canzonieri V; D'Amore ES; Bartoloni G; Piazza M; Blandamura S; Carbone A
    Virchows Arch; 1994; 425(5):541-5. PubMed ID: 7850080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Bodner-Adler B; Bartl M; Wagner G
    Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening.
    Garg K; Rabban J
    Genes Chromosomes Cancer; 2021 Mar; 60(3):210-216. PubMed ID: 33099845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.